Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04891978 · ClinicalTrials.gov registry record · NA
US PRECISION Implementation Study
A NA study, sponsored by AstraZeneca.
- Completed
- Registry status
- NA
- Development phase
- 857
- Enrollment target
NCT04891978: Completed NA study, sponsored by AstraZeneca.
NCT04891978 is a NA study that has completed, run by AstraZeneca. The registered enrollment target is 857 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04891978, a NA study, has completed, sponsored by AstraZeneca.
- COMPLETED
- Registry status
- NA
- Development phase
- 857 participants
- Enrollment target
Study Summary
The primary objective of this community program intervention study is to assess the process and potential benefits of integrating the AIRQ®, Asthma Checklist, and educational resources (PRECISION program) into clinical practice using either in-person or telehealth visits. The secondary objectives are to assess asthma patients' clinic visit experiences when the AIRQ, the Asthma Checklist, and educational resources (PRECISION program) are utilized as part of a telehealth or in-person visit with their HCP, and to explore change in AIRQ scores from the initial visit to follow-up visit(s) (when available).
Primary Outcome
The post-study HCP survey includes questions regarding the implementation of the PRECISION program (e.g., how would you rate the overall ease of implementing the AIRQ into your clinical practice using the telehealth platform?)
Interventions
- BEHAVIORAL AIRQ
- BEHAVIORAL Asthma Checklist
- BEHAVIORAL PRECISION Program (Educational Resources)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 857 participants |
| Start Date | 2021-04-20 |
| Est. Completion | 2023-04-30 |
| Phase | NA |
What the finished NCT04891978 record still lists
NCT04891978 is an interventional study that assigns participants to a tested intervention. The registered 857 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (39% lower).
The record links to 0 conditions, and to 3 interventions - of which AIRQ is the first listed.
NCT04891978 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04891978 about?
NCT04891978 is a clinical study titled "US PRECISION Implementation Study". The primary objective of this community program intervention study is to assess the process and potential benefits of integrating the AIRQ®, Asthma Checklist, and educational resources (PRECISION program) into clinical practice using either in-person or telehealth visits. The secondary objectives a...
What is the current status of trial NCT04891978?
This trial is currently completed. It is a NA study. The enrollment target is 857 participants. The study started on 2021-04-20. Estimated completion is 2023-04-30.
What interventions are being tested in trial NCT04891978?
The interventions under investigation include: AIRQ (BEHAVIORAL), Asthma Checklist (BEHAVIORAL), PRECISION Program (Educational Resources) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04891978?
This trial is sponsored by AstraZeneca, which has 1,285 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04891978's enrollment target sits among peer trials
857 130th of 2000 higher than 1,871 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06231485 · 856 participants · NA
Socialization To Enrich Participation & Support Sexuality for Young People With I/DD
- NCT05108896 · 855 participants · NA
Aspiration in Acute Respiratory Failure Survivors 2
- NCT04541381 · 860 participants · NA
The PhOCus Trial: Implementation of Pharmacogenomic Testing in Oncology Care
- NCT05211895 · 860 participants · Phase 3
A Global Study to Assess the Effects of Durvalumab + Domvanalimab Following Concurrent Chemoradiation in Participants With Stage III Unresectable NSCLC
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI